We use cookies to enhance your browsing experience and analyze site traffic. By continuing to use this site, you agree to our cookie policy. Privacy Policy
Clickmab is focused on AI-driven antibody design. Built on proprietary large models, extensive proprietary antibody data, and a multi-agent architecture, the Click.mAb. platform supports antibody discovery and engineering optimization across the full R&D workflow for biopharmaceutical teams.
User-specified functional epitope
De novo designed antibody
The platform supports both de novo design and rapid optimization, enabling antibody design against specific antigen epitopes through generative AI models.
It also supports rapid iterative optimization of known antibodies through an integrated computational and wet-lab workflow, making it applicable to a wide range of antibody discovery scenarios.
Large-scale proprietary wet-lab data ensures model training accuracy and reliability
Proprietary AI antibody design algorithms at the global frontier for precise and efficient design
Multi-agent collaboration for fully automated antibody R&D workflows
An interdisciplinary elite team of AI experts, structural biologists, antibody engineers, and wet-lab scientists
Top-tier AI algorithm, protein language model, and structure prediction team.
Deep understanding of biophysical principles of protein structure and function.
Senior expertise in antibody engineering and drug development.
In-house wet-lab team enabling rapid computation-experiment feedback loops.
Whether you are a pharmaceutical company, biotech firm, or academic institution, we look forward to exploring collaboration opportunities